Top

Journal of Experimental & Clinical Cancer Research

Published in:

Open Access 01-12-2022 | Metastasis | Correction

Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

Authors: Neng Wang, Qi Wang, Hailin Tang, Fengxue Zhang, Yifeng Zheng, Shengqi Wang, Jin Zhang, Zhiyu Wang, Xiaoming Xie

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2022

Excerpt

Correction to: J Exp Clin Cancer Res 36, 172 (2017) …

Available only for authorised users

Wang N, Wang Q, Tang H, et al. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells. J Exp Clin Cancer Res. 2017;36:172. https://doi.org/10.1186/s13046-017-0635-9.CrossRefPubMedPubMedCentral

Title: Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells
Authors: Neng Wang
Qi Wang
Hailin Tang
Fengxue Zhang
Yifeng Zheng
Shengqi Wang
Jin Zhang
Zhiyu Wang
Xiaoming Xie
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Metastasis
Breast Cancer
Breast Cancer
Published in: Journal of Experimental & Clinical Cancer Research / Issue 1/2022
Electronic ISSN: 1756-9966
DOI: https://doi.org/10.1186/s13046-022-02341-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy

The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy

NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer

Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression

Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling

SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer